Prime Medicine Inc
(PRME)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRME | AZN | AMGN | GILD | GSK |
| Company | Prime Medicine Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.28 | 212.66 | 373.50 | 156.01 | 61.54 |
| High | 3.39 | 212.71 | 379.81 | 156.01 | 61.70 |
| Low | 3.22 | 207.55 | 370.44 | 152.76 | 60.99 |
| Latest | 3.29 | 208.21 | 378.96 | 153.06 | 61.09 |
| Change | -0.02 | -1.27 | +5.60 | -2.21 | +0.22 |
| % Change | -0.60% | -0.61% | +1.50% | -1.42% | +0.36% |
| Volume | 576,550 | 1,647,700 | 980,055 | 1,905,262 | 3,459,015 |
| 20-Day Average Volume | 2,564,534 | 3,056,653 | 3,022,229 | 8,322,561 | 6,578,857 |
| Previous Close | 3.31 | 209.48 | 373.36 | 155.27 | 60.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.76 | 192.05 | 358.02 | 145.03 | 54.88 |
| 20-Day Raw Stochastic | 10.36% | 85.45% | 89.93% | 88.79% | 96.41% |
| 20-Day Relative Strength | 42.21 | 65.69 | 65.19 | 66.75 | 76.17 |
| Weighted Alpha | -26.05 | +49.63 | +34.69 | +50.74 | +80.73 |
| Today's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 64% Buy | 72% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.07% since 02/10/26 | +7.38% since 02/10/26 | +4.07% since 02/10/26 | +4.01% since 02/10/26 | +3.76% since 02/10/26 |
| Low | 3.15 on 02/17/26 | 199.19 on 02/11/26 | 361.00 on 02/11/26 | 147.38 on 02/11/26 | 58.01 on 02/11/26 |
| High | 3.50 on 02/12/26 | 212.71 on 02/18/26 | 379.81 on 02/18/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | -16.71% since 01/16/26 | +10.01% since 01/16/26 | +14.86% since 01/16/26 | +22.59% since 01/16/26 | +26.57% since 01/16/26 |
| Low | 3.15 on 02/17/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 47.62 on 01/20/26 |
| High | 4.70 on 01/22/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | -6.62% since 11/18/25 | +15.95% since 11/18/25 | +10.32% since 11/18/25 | +20.40% since 11/18/25 | +28.84% since 11/18/25 |
| Low | 3.15 on 02/17/26 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.81 on 11/20/25 |
| High | 4.70 on 01/22/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -5.29% since 08/18/25 | +31.24% since 08/18/25 | +29.69% since 08/18/25 | +29.78% since 08/18/25 | +56.21% since 08/18/25 |
| Low | 3.08 on 08/20/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 6.94 on 10/06/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 597,491 | 324,884,192 | 201,047,264 | 192,640,400 | 124,077,768 |
| Shares Outstanding, K | 180,511 | 1,550,908 | 538,481 | 1,240,680 | 2,038,406 |
| Annual Sales | 2,980,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -195,880,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 1,230,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -50,580,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 2.70 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/07/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 02/27/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.426 on 11/14/25 |
| Next Ex-Dividends Date | 09/10/19 | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.38 | 16.90 | 19.02 | 13.04 |